Member Info for Prion25

The next to useless PSA and Digital Rectal examination have been approved in US by the FDA in 1990 ‘s The PSE test stated in RNS will run along side the PSA then if you are told your PSA is elevated and PSE is negative would a medical practitioner recommend a biopsy or go with a 96 % validated 3D 150 Data points genetic test result

Https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012513/

Weekend Reading on the mRNA vax topic and impaired interferon ie if you are not already exhausted with confounding immunology then its worth a glance GLA

Good find Brand more confounding factors to be investigated in immunology

Https://www.bbc.co.uk/news/technology-66394406

loadsoflolly

I posted this over a month ago and Lemos is mentioned Also in another earlier report Jeremy Hunt talks of creating a UK Silicon Valley It all sound hopeful But there are lots of buts

ATB

Thanks @nothopeful

Good explanation

I have added this for to stress the importance

https://academicentrepreneurship.pubpub.org/pub/1fani3y6/release/3

Never come across reimbursement codes before can someone explain in simple terms what are the significance of these ?

I have been in this share the late 1990's when they started up in Newport and Arm holdings excited the chip industry .Yes there have been many false dawns for sure but just hoping with the new CEO ,new innovation and a new technological era

Lord loadsoflolly

Nothing wrong in being cautious and making evidence based decisions But you would think that IQE involvement in supplying tech for autonomous vehicles and now AI etc would benefit sentiment and attract institutional investors and lift the SP

ATB

From today’s News l like the bit below mentions AI must be good for the future?

, IQE is further demonstrating the technology's scalability, enabling a step change in volume manufacturing to satisfy an increasing demand for DFB lasers. This also ensures optical interconnect technology remains cost competitive, as network traffic scales to meet the requirements of generative AI and data intensive applications.

* population screening

Routine screening with MRI scanning for prostate cancer may be a decade away ref BBC news yesterday

NHS adopted the next to useless PSA test If you listen to the CEO they cannot improve on validation or statistical significance as the data they possess for each patient has a 3D conformation genetic changes containing hundreds of data points The epi switch is unique tech compared to PSA and of course more data will evolve

Https://www.reuters.com/technology/big-pharma-bets-ai-speed-up-clinical-trials-2023-09-22/

“Merits further investigation “ very disappointing to hear those words and SNG appears to be doing nothing likewise with COPD ? Talking of which on BBC Morning Live demonstrated a device that can diagnose COPD using AI instead of a spirometer .AI seems the way forward in clinical trials and pulmonary medicine just hope SNG are embracing the new tech

Goldman Sachs cuts Ceres Power price target to 510 (540) pence - 'buy'

Had this email this morning from Prostate Cancer UK to which I make donations .Interesting they refer research to resistance to treatments and a new delivery system to treat resistance tumours Resistance appears to be a big problem and Avacta to be very much ahead in this field of research

"Thanks to many years of research, supported by you, treatments for prostate cancer are more effective than ever.

But for some men, their prostate cancer can become resistant to treatment and start to grow again. With your help, we’re funding researchers like Professor John Callan from Ulster University to develop new treatments that overcome this resistance. "

Professor Callan and his team have found a new combination of treatments, and a unique way to deliver them, that they believe can help control prostate cancer that has come back - packaging chemotherapy drugs in microscopic bubbles.

It sounds like science fiction, but if it works, this microbubble treatment would be more targeted than existing treatments, reducing side effects and improving and extending the lives of men with prostate cancer

2026 is over cautious to allow for any bumps in the road if positive P2 it will be fast track and AS will be well within the target

Http://otp.investis.com/clients/uk/oxford_biodynamics_plc/rns/regulatory-story.aspx?cid=2040&newsid=936155

No body mentioned the importance of epi switch patents which will of great interest to Big Pharma

Cost £1190 worth every penny but what concerns me is the low numbers of patients in the validation process Hope to buy a few today

Ironically he also plaudits dexamethasone which was our downfall

Https://www.phosp.org/

I wonder if SNG are involved in PHOSP covid study ?